December 7, 2017 Acad, Gov/Utilities Atomic Spectroscopy Life Science Tools Product Launch

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes Oncomine Myeloid Research Assay leverages Thermo Fisher’s next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — Clinical researchers interested in studying driver mutations suspected... Read more

December 6, 2017 Acad, Gov/Utilities Lab Top-10 Product Launch

Free Webinar On-Demand: New Cleanliness Workflow from Leica and Pall

Obtaining cleanliness results rapidly, accurately, and reliably is a significant advantage for manufacturers and component suppliers. For this reason, Pall Corporation and Leica Microsystems have joined efforts to offer a new, unique workflow solution customizable to your individual needs. Join our free webinar to get a sneak preview on Leica Microsystems’ new fully implemented LIBS... Read more

December 6, 2017 Acad, Gov/Utilities Lab Top-10 Product Launch

Watch the Webinar On-Demand: New Cleanliness Workflow from Leica and Pall

Classical polarized light (compound) microscopes can only be used for prepared samples, because the working distance they offer is insufficient for whole samples. This means that thicker and bigger geological samples have to be sectioned and polished to fit under the limited working distance of a compound microscope. The Leica DVM 6 provides outstanding image... Read more

December 5, 2017 Acad, Gov/Utilities Clinical Research/Diagn.

TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) FDA partial clinical hold lifted

Basel, 05 December 2017 TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) FDA partial clinical hold lifted Roche (SIX: RO, ROG; OTCQX: RHHBY): today announced that following close consultation and agreement on study modifications with the U.S. Food and Drug Administration (FDA), the partial clinical holds placed on the Phase Ib and Phase Ib/II studies evaluating TECENTRIQ... Read more

December 4, 2017 Acad, Gov/Utilities Clinical Research/Diagn.

FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

Basel, 04 December 2017 FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved FoundationOne CDx™, Foundation Medicine’s comprehensive companion diagnostic assay for personalised oncology care1. FoundationOne... Read more

November 30, 2017 Acad, Gov/Utilities Chromatography Lab Top-10 Mass Spectrometry Microscopy Product Launch

Shimadzu's New TD-30 Series of Thermal Desorption Systems for Gas Chromatographs and GCMS Systems Provides Accurate Analysis of Volatile Compounds

A thermal desorption system is a pretreatment unit in which a tube that concentrates volatile components is heated, and the volatile components from the tube are loaded into an analytical instrument with high sensitivity. It has been used for the analysis of toxic substances in the atmosphere and substances responsible for sick house syndrome included... Read more

November 21, 2017 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Environ, Ag./Food & Bev Lab Top-10 Licensing, IP, and Legal

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more